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Results: Comparing with the control group and sham-
operated group, inﬂammation occurred and collagen
content increased, the expression of IGFBPrP1, Collagen
III, p-Smad2/3, Smad3 increased in liver tissue of Operation
group (P < 0.01). While the differences of those in lung
tissue were not signiﬁcant (P < 0.05). More TUNEL positive
cells were found in operative group than normal group and
sham-operated group (P < 0.01).
Conclusion: Exogenous IGFBPrP1 released at a continuous
constant dose may induce hepatic ﬁbrosis of mice. On the
same condition, the effect of IGFBPrP1 on mice lung tissue
was weaker than that on hepatic tissue and pulmonary
ﬁbrosis was not found. IGFBPrP1 maybe has a selectively
functions on mice tissue.
PP-155 The effect of exogenous IGFBPrP1 on liver and
kidney in mice
L.X. Liu1, H.Y. Zhang1 *, Q.Q. Zhang1. 1The First Hospital
of Shanxi Medical University, China
Objectives: To investigate the effect of exogenous
recombinant mouse insulin-like growth factor binding
protein related protein 1 (rmIGFBPrP1) on both liver and
kidney tissue with mouse, explore the mechanism of
rmIGFBPrP1 on ﬁbrosis.
Methods: A total of 26 clean male wild-type C57BL/6 mice
were randomly divided into normal control group, sham-
operated group and model group. We used rmIGFBPrP1
which was released by capsule osmotic pump to make the
model. HE staining and Sirius red staining were observed to
investigate the pathological changes, deposition of collagen
ﬁbers of both liver and kidney of mice. The expression and
distribution of IGFBPrP1, Smad3, p-Smad2/3, III collagen
(Collagen III) of liver and kidney tissues were detected by
immunohistochemistry. Hepatocyte apoptosis was detected
by DUTP nick end labeling (TUNEL).
Results: Comparing with the control group and sham-
operated group, the content of collagen ﬁber increased,
expression of IGFBPrP1, Smad3, p-Smad2/3, Collagen III
increased (P < 0.01) in the liver of model group. Only
the expression of IGFBPrP1 in the kidney of model group
increased than the control group and sham-operated group
(P < 0.01), there is no difference on collagen ﬁbers content
and Other indicators expression (P > 0.05). TUNEL showed an
increase in ratio of apoptotic liver cells in model group than
the normal group and sham-operated group, the difference
was statistically signiﬁcant (P < 0.01).
Conclusion: Exogenous IGFBPrP1 can promote hepatocyte
apoptosis and liver ﬁbrosis, but have little effect on the
mice kidney. IGFBPrP1 maybe has the selectivity on inducing
organs and organization ﬁbrosis of mouse.
PP-156 IGFBPrP1 siRNA induced apoptosis in rat hepatic
stellate cells and its mechanism
L.X. Liu1 *, X.H. Guo1, Q.Q. Zhang1. 1The First Hospital of
Shanxi Medical University, China
Objectives: To investigate the inﬂuence of inhibiting
insulin-like growth factor binding protein related protein1
(IGFBPrP1) by chemically synthesized small interfering RNA
(siRNA) on apoptosis of HSC-T6 cells and to explore the
possible mechanism.
Methods: Divide the HSC-T6 cells into three groups as
following: normal control group, negative control group
and IGFBPrP1 siRNA transfection group. The IGFBPrP1 siRNA
was transfected into HSC-T6 cells. After transfecting with
different time, cell proliferation was measured by CCK-8
assay, cell apoptosis was detected by ﬂow cytometry with
AnnexinV/PI double staining, both p53 and bcl-2 protein
expressions were detected by immunocytochemistry.
Results: (24 h, 48 h, 72 h) after IGFBPrP1 siRNA transfection,
the rates of proliferation inhibition were (25%, 32%, 28%);
apoptotic rates of IGFBPrP1 siRNA transfection groups
were increased compared with the normal control group
and the negative control group, respectively, (P < 0.01).
Immunocytochemistry showed that the expression of p53
protein was signiﬁcantly increased and the expression of
bcl-2 protein was signiﬁcantly decreased compared with
the normal control group and the negative control group,
respectively, (P < 0.01).
Conclusion: IGFBPrP1 siRNA is able to inhibite the cell
proliferation signiﬁcantly and induce apoptosis of HSC-T6
cells effectively. Apoptosis of HSC-T6 cells induced by
IGFBPrP1 siRNA may be associated with up-regulation of
p53 expression and down-regulation of bcl-2 expression.
RNAi against IGFBPrP1 may provide a new strategy for the
treatment of liver ﬁbrosis.
PP-157 Portal application of autologous CD133+
bone marrow cells to induce liver regeneration
in a patient with cirrhosis
Y.N. Li1 *, G.H. Han2, W.Q. Wu1, J.J. Zhou1,3, W. Bai3,
M.L. Li1. 1Depart.of Infec. Dis., The 323 Military Hospital,
2Department of Digestive Diseases, Xijing Hospital, The
Fourth Military Medical University, 3Centre for Stem cell
Research, The 323 Military Hospital, China
More and more efforts have been making in order
to trigger hepatocyte regeneration through autological
bone marrow stem cells in severe chronic liver disease
although the condition and mechanism of bone marrow
stem cell differentiation into hepatocyte remains blurred.
We report a case of compensated cirrhosis induced by
chronic hepatitis B. The patient accepted portal infusion of
autologous CD133+ mononuclear cells combined with portal
vein embolisation after granulocyt colohy-stimulatins factor
(G-CSF) mohilization, bone marrow stem cells collection
and selection.A mild ﬂare of serum bilirubin, alanine
aminotransferase, albumin, fetoproten and blood platelet
count were observed within two weeks after procedure.
The serum aspartate aminotransferase and white blood
cell count showed a temporary raise, then returned to
basis level rapidly. The most import observation is the
hepatic volumetry of segment concerned stem cells infusion
signiﬁcantly increased from 368ml to 468ml three months
later after therapy. No obvious reactions and comlications
were found in this patient. Intrahepatic infusion of bone
morrow stem cells seemed safe and associates with
enlarging hepatic functional remnant volume, a promising
approach to accelerate the repopulation of hepatocytes in
patient with cirrhosis.
PP-158 Steroid resistance: the main blockhouse in the
treatment of alcoholic hepatitis
F. Wang1 *, B.-Y. Wang1. 1Department of gastroenterology,
the First Afﬁliated Hospital of China Medical University,
China
Alcoholic hepatitis (AH) is a necrotizing inﬂammatory lesion
of alcoholic liver injury with signiﬁcant short-term mortality.
The management of AH is challenging. Corticosteroids,
demonstrated anti-inﬂammatory and antiﬁbrotic effects,
are the most intensely studied and yet most hotly debated
treatment for AH. There are more than 17 controlled
trials and at least 13 meta-analyses about corticosteroids
treatment in AH in the past 40 years. Many of them are
poorly designed and varying in inclusion/exclusion criteria,
which make it hard to reach a consensus conclusion. To
resolve this confounding, researchers in both sides of the
controversy all made Cochrane review through combining
